题名 | Immunomodulatory potential of mesenchymal stem cell-derived extracellular vesicles: Targeting immune cells |
作者 | |
通讯作者 | Li, Haihong; Fu, Xiaobing; Zhang, Cuiping |
发表日期 | 2023-02-13
|
DOI | |
发表期刊 | |
ISSN | 1664-3224
|
卷号 | 14 |
摘要 | Various intractable inflammatory diseases caused by disorders of immune systems have pressed heavily on public health. Innate and adaptive immune cells as well as secreted cytokines and chemokines are commanders to mediate our immune systems. Therefore, restoring normal immunomodulatory responses of immune cells is crucial for the treatment of inflammatory diseases. Mesenchymal stem cell derived extracellular vesicles (MSC-EVs) are nano-sized double-membraned vesicles acting as paracrine effectors of MSCs. MSC-EVs, containing a variety of therapeutic agents, have shown great potential in immune modulation. Herein, we discuss the novel regulatory functions of MSC-EVs from different sources in the activities of innate and adaptive immune cells like macrophages, granulocytes, mast cells, natural killer (NK) cells, dendritic cells (DCs) and lymphocytes. Then, we summarize the latest clinical trials of MSC-EVs in inflammatory diseases. Furthermore, we prospect the research trend of MSC-EVs in the field of immune modulation. Despite the fact that the research on the role of MSC-EVs in regulating immune cells is in infancy, this cell-free therapy based on MSC-EVs still offers a promising solution for the treatment of inflammatory diseases. |
关键词 | |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 通讯
|
资助项目 | National Nature Science Foundation of China["22205260","82172211","81830064","82172231"]
; National Key Research and Development Programs of China[2022YFA1104303]
; CAMS Innovation Fund for Medical Sciences (CIFMS)[2019-I2M-5-059]
; Military Medical Research and Development Projects["AWS17J005","2019-126"]
; Military Medical Science and Technology Youth Training Program[21QNPY128]
|
WOS研究方向 | Immunology
|
WOS类目 | Immunology
|
WOS记录号 | WOS:000939552400001
|
出版者 | |
来源库 | Web of Science
|
引用统计 |
被引频次[WOS]:23
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/583143 |
专题 | 南方科技大学医学院 南方科技大学医院 |
作者单位 | 1.Chinese Peoples Liberat Army Gen Hosp, Res Ctr Tissue Repair & Regenerat, Med Innovat Res Div, Beijing, Peoples R China 2.Chinese Peoples Liberat Army Gen Hosp, Med Ctr 4, Beijing, Peoples R China 3.PLA Army, Inst NBC Def, Beijing, Peoples R China 4.China Acad Chinese Med Sci, Xiyuan Hosp, Dept Dermatol, Beijing, Peoples R China 5.Chinese Acad Med Sci, Res Unit Trauma Care Tissue Repair & Regenerat, Beijing, Peoples R China 6.Capital Med Univ, Beijing Chaoyang Hosp, Dept Ophthalmol, Beijing, Peoples R China 7.Southern Univ Sci & Technol, Southern Univ Sci & Technol Hosp, Inst Wound Repair & Regenerat Med, Sch Med,Dept Wound Repair, Shenzhen, Peoples R China |
通讯作者单位 | 南方科技大学医学院; 南方科技大学医院 |
推荐引用方式 GB/T 7714 |
Liu, Xi,Wei, Qian,Lu, Lu,et al. Immunomodulatory potential of mesenchymal stem cell-derived extracellular vesicles: Targeting immune cells[J]. FRONTIERS IN IMMUNOLOGY,2023,14.
|
APA |
Liu, Xi.,Wei, Qian.,Lu, Lu.,Cui, Shengnan.,Ma, Kui.,...&Zhang, Cuiping.(2023).Immunomodulatory potential of mesenchymal stem cell-derived extracellular vesicles: Targeting immune cells.FRONTIERS IN IMMUNOLOGY,14.
|
MLA |
Liu, Xi,et al."Immunomodulatory potential of mesenchymal stem cell-derived extracellular vesicles: Targeting immune cells".FRONTIERS IN IMMUNOLOGY 14(2023).
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论